Cargando…

Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649

Detalles Bibliográficos
Autores principales:	König, Christina, Both, Anna, Rohde, Holger, Kluge, Stefan, Frey, Otto R., Röhr, Anka C., Wichmann, Dominic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532813/ https://www.ncbi.nlm.nih.gov/pubmed/34680855 http://dx.doi.org/10.3390/antibiotics10101230

Ejemplares similares

Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
por: König, Christina, et al.
Publicado: (2021)

Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol
por: Zimmer, Julia, et al.
Publicado: (2021)

Virulence Profile: Renate König
por: König, Renate
Publicado: (2017)

Angélique und der König : roman /
por: Golon, Anne
Publicado: (1965)

Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
por: Bilal, Muhammad, et al.
Publicado: (2021)

Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting
por: Perea, José Ramón Azanza, et al.
Publicado: (2022)

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients
por: Zahr, Noël, et al.
Publicado: (2022)

Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin
por: Katsube, Takayuki, et al.
Publicado: (2019)

1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients
por: Katsube, Takayuki, et al.
Publicado: (2020)

Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia
por: Katsube, Takayuki, et al.
Publicado: (2021)

Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration
por: Kobic, Emir, et al.
Publicado: (2021)

Experimental Study on Potential Influence of the Invasive Hedychium coronarium J. König on the Evapotranspiration of Riparian Plant Community
por: Vergne, Driélli de Carvalho, et al.
Publicado: (2023)

Influence of microbiological diagnosis on the clinical course of spondylodiscitis
por: Stangenberg, Martin, et al.
Publicado: (2021)

Cefiderocol
por: Soriano, María Cruz, et al.
Publicado: (2022)

Pauli Obituary Collection: "Besuch König Baudoins im CERN", in: Die Neue Zürcher Zeitung (NZZ), article
por: [unknown]
Publicado: (2004)

Erratum to: Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia
por: Katsube, Takayuki, et al.
Publicado: (2021)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG(2) Monoclonal Antibody, in Healthy Volunteers
por: Mathur, Mohit, et al.
Publicado: (2022)

Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: Schatz, Lea Marie, et al.
Publicado: (2023)

Potential bangle (Zingiber montanum J.König) rhizome extract as a supplement to prevent and reduce symptoms of Covid-19
por: Musdja, Muhammad Yanis
Publicado: (2021)

Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects
por: Katsube, Takayuki, et al.
Publicado: (2019)

Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2021)

1734. Susceptibility of Cefiderocol between US Census Regions against Gram-Negative Organisms collected from the SENTRY Surveillance Program: 2020-2021
por: Kung, Frank H, et al.
Publicado: (2022)

649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium
por: Kim, Si-Ho, et al.
Publicado: (2018)

Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2022)

Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment
por: Chiriac, Ute, et al.
Publicado: (2021)

Clinical experience of cefiderocol
por: Fariñas, María Carmen
Publicado: (2022)

Mechanism of action of cefiderocol
por: Soriano, Alex, et al.
Publicado: (2022)

Cefiderocol. Summary and conclusions
por: Mensa, José, et al.
Publicado: (2022)

Antibacterial spectrum of cefiderocol
por: Cordero, Desirée Gijón, et al.
Publicado: (2022)

739. Prediction of Cefiderocol Pharmacokinetics and Probability of Target Attainment in Pediatric Subjects for Proposing Dose Regimens
por: Katsube, Takayuki, et al.
Publicado: (2019)

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series
por: Mornese Pinna, Simone, et al.
Publicado: (2022)

Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study
por: Alihodzic, Dzenefa, et al.
Publicado: (2022)

Freeze-Dried Softisan(®) 649-Based Lipid Nanoparticles for Enhanced Skin Delivery of Cyclosporine A
por: Silva, Maria Inês, et al.
Publicado: (2020)

SUN-649 Metabolic and Functional Regulation of T Cells by Insulin and Insulin like Growth Factor 1
por: Kiernan, Kaitlin, et al.
Publicado: (2020)

The role of cefiderocol in clinical practice
por: Maseda, Emilio, et al.
Publicado: (2022)

Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects
por: Saisho, Yutaka, et al.
Publicado: (2018)

Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment
por: Katsube, Takayuki, et al.
Publicado: (2016)

1311. Intrapulmonary Pharmacokinetics of Cefiderocol in Hospitalized and Ventilated Patients Receiving Standard of Care Antibiotics for Bacterial Pneumonia
por: Katsube, Takayuki, et al.
Publicado: (2020)

Intrapulmonary Pharmacokinetic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients With Pneumonia and Healthy Subjects
por: Kawaguchi, Nao, et al.
Publicado: (2022)

In Vitro Activity of Cefiderocol on Multiresistant Bacterial Strains and Genomic Analysis of Two Cefiderocol Resistant Strains
por: Padovani, Michela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aul0kah51usaf2qcfqodi7v92s